Cart
sales@molnova.com
Chlorthenoxazine
CAS No. 132-89-8
Chlorthenoxazine( Chlorethylbenzmethoxazone )
Catalog No. M26647 CAS No. 132-89-8
Chlorthenoxazine has anti-inflammatory activity.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 70 | In Stock |
|
| 5MG | 71 | In Stock |
|
| 10MG | 101 | In Stock |
|
| 25MG | 181 | In Stock |
|
| 50MG | 277 | In Stock |
|
| 100MG | 403 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameChlorthenoxazine
-
NoteResearch use only, not for human use.
-
Brief DescriptionChlorthenoxazine has anti-inflammatory activity.
-
DescriptionChlorthenoxazine has anti-inflammatory activity.
-
In Vitro——
-
In Vivo——
-
SynonymsChlorethylbenzmethoxazone
-
PathwayOthers
-
TargetOther Targets
-
RecptorAnti-infection| Bacterial
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number132-89-8
-
Formula Weight211.65
-
Molecular FormulaC10H10ClNO2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESClCCC1NC(=O)c2ccccc2O1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Yoshimura H, et al. Comparative in vitro activity of 16 antimicrobial agents against Actinobacillus pleuropneumoniae. Vet Res Commun. 2002 Jan;26(1):11-9.
molnova catalog
related products
-
Furaprofen
Furaprofen is an orally available, selective and potent HCV inhibitor with anti-inflammatory activity, inhibits carrageenan-induced paw edema in rats and inhibits cotton pellet-induced granulomas in rats at higher doses.
-
Axillarin
Axillarin has antioxidant activity, it shows xanthine oxidase inhibitory activity ( IC(50) :36.0 uM).
-
Peptide YY (canine, ...
Peptide YY (pig) is a 36 amino acid gastrointestinal peptide, can be isolated from porcine duodenum. Peptide YY (pig) decreases appetite and food-intake by activation of the Y2 receptor. Peptide YY (pig) is present mainly in pancreatic endocrine cells with effect on both intestinal motility and the cardiovascular system.
